Raymond James Financial Inc. Acquires Shares of 35,900 Semler Scientific, Inc. (NASDAQ:SMLR)

Raymond James Financial Inc. purchased a new stake in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 35,900 shares of the company's stock, valued at approximately $1,939,000. Raymond James Financial Inc. owned about 0.39% of Semler Scientific as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Charles Schwab Investment Management Inc. boosted its stake in shares of Semler Scientific by 9.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 43,823 shares of the company's stock valued at $1,032,000 after purchasing an additional 3,925 shares during the period. Verition Fund Management LLC purchased a new position in Semler Scientific in the 3rd quarter valued at approximately $251,000. State Street Corp boosted its position in Semler Scientific by 0.6% in the 3rd quarter. State Street Corp now owns 118,223 shares of the company's stock valued at $2,784,000 after buying an additional 725 shares during the period. Jane Street Group LLC grew its stake in shares of Semler Scientific by 72.3% in the third quarter. Jane Street Group LLC now owns 16,982 shares of the company's stock worth $400,000 after acquiring an additional 7,126 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Semler Scientific by 10.5% during the third quarter. Geode Capital Management LLC now owns 135,959 shares of the company's stock worth $3,202,000 after acquiring an additional 12,964 shares during the period. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital lifted their target price on Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a report on Friday, January 24th.

Semler Scientific Price Performance

Shares of SMLR stock traded down $1.14 during trading hours on Friday, reaching $32.92. 225,970 shares of the stock were exchanged, compared to its average volume of 388,420. The business's fifty day moving average is $43.29 and its two-hundred day moving average is $44.94. The firm has a market capitalization of $315.93 million, a P/E ratio of 6.74 and a beta of 1.29. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $81.56.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping the consensus estimate of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The company had revenue of $12.41 million during the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.